ArticleCancers2026
Novel Cell Cycle Inhibitors Decrease Primary and Metastatic Breast Cancer Growth In Vivo.
Mir Shahid Maqbool, Yongzhan Zhang, Karin Strittmatter, Ana Gvozdenovic, Simran Asawa, Masroor A Paddar, Mukesh Kumar, Umed Singh, Parvinder Pal Singh, Nicola Aceto and 1 more
Abstract read
In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Mir Shahid MaqboolDivision of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Sanat Nagar, Srinagar 190005, Jammu & Kashmir, India.ORCID 0000-0003-4531-6220 Yongzhan ZhangDepartment of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology Zurich (ETH Zurich), 8093 Zurich, Switzerland.
Karin StrittmatterDepartment of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology Zurich (ETH Zurich), 8093 Zurich, Switzerland.
Ana GvozdenovicDepartment of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology Zurich (ETH Zurich), 8093 Zurich, Switzerland.
Simran AsawaDepartment of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology Zurich (ETH Zurich), 8093 Zurich, Switzerland.
Masroor A PaddarDivision of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Sanat Nagar, Srinagar 190005, Jammu & Kashmir, India.
Mukesh KumarDivision of Medicinal Chemistry, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, Jammu & Kashmir, India.
Umed SinghDivision of Medicinal Chemistry, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, Jammu & Kashmir, India.ORCID 0000-0003-0683-7533 Parvinder Pal SinghDivision of Medicinal Chemistry, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, Jammu & Kashmir, India.
Nicola AcetoDepartment of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology Zurich (ETH Zurich), 8093 Zurich, Switzerland.ORCID 0000-0001-9579-6918 Fayaz MalikDivision of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Sanat Nagar, Srinagar 190005, Jammu & Kashmir, India.ORCID 0000-0001-5475-6610 Funding
Indo-Swiss Joint Research Grant BT/IN/Swiss/48Swiss National Science Foundation IZLIZ3_182962
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
breast cancercirculating tumor cellsdrug screenmouse model
Identifiers
PMID41681937
PMCPMC12896542
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390